Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Alzheimer’s diagnostic start-up Neurotrack completes $2mm Series A financing

Executive Summary

Founders Fund led a $2mm Series A round for Neurotrack Inc., which aims to market a pre-symptomatic Alzheimer’s diagnostic. Twelve other investors participated, including the Social+Capital Partnership and individual angels Peter Thiel and Chamath Palihapitiya.
Deal Industry
  • In Vitro Diagnostics
Deal Status
  • Final
Deal Type
  • Financing
    • Venture Financing

Related Companies